RADAR-GO: Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea
RADAR-GO: Launch of an interdisciplinary project to develop a much needed test for antibiotic resistant Gonorrhoea.
SwissTransMed is funding the project RADAR-Go (Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea) to develop a rapid molecular test for antibiotic resistance and to predict its impact using mathematical modeling.
Gonorrhoea is a sexually transmitted infection that is becoming increasingly difficult to treat due to antibiotic resistance. Standard tests for antibiotic resistance can take up to three days and currently used rapid diagnostic tests do not detect antibiotic resistance. This leads to delayed and often inadequate antibiotic therapy. RADAR-Go aims to solve these problems and provide essential tools for future monitoring and treatment of antibiotic resistant gonorrhoea.
RADAR-Go will run until the end of 2016. The project is led by Prof. Nicola Low at the Institute of Social and Preventive Medicine (ISPM) in Bern. Collaborators are: the Institute of Infectious Diseases (IFIK) in Bern, ETH Zurich, Bern University Hospital and the Clinical Trials Unit in Bern.
- CDC Fact Sheet
- WHO’s Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae
- Low N, et al. Molecular diagnostics for Gonorrhoea: Implications for antimicrobial resistance and the threat of untreatable Gonorrhoea. PLoS Med. 2014 Feb 4;11(2):e1001598